Human epithelial ovarian cancer xenotransplants into nude mice can be cured by adenovirus-mediated thymidine kinase gene therapy

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 811-813

  Tong, X W ^a   Agoulnik, I ^a   Blankenburg, K ^a   Contant, C F ^a   Hasenburg, A ^a   Runnebaum, I B ^b   Stickeler, E ^a   Kaplan, A L ^a   Woo, S L C ^a   Kieback, Dirk G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

Gene therapy; Ovarian cancer; Thymidine kinase; Xenotransplants

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; GENE THERAPY; GENETIC TRANSDUCTION; INJECTION SITE; MOUSE; NONHUMAN; OVARY ADENOCARCINOMA; OVARY CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUICIDE GENE; SURVIVAL; XENOGRAFT;

ADENOVIRIDAE; ANIMALS; FEMALE; GENE THERAPY; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; THYMIDINE KINASE; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0030895588     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Moolten FL: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 46: 5276-5281, 1986.
2. Moolten FL and Cupples LA: A model for predicting the risk of cancer consequent to retroviral gene therapy. Hum Gene Ther 3: 479-486 1992.
3. Moolten FS, Wells JM and Mroz PJ: Multiple transduction as a means of preserving ganciclovir chemosensitivity in sarcoma cells carrying retrovirally transduced herpes thymidine kinase genes. Cancer Letters 64: 257-263, 1992.
4. Moolten FL and Wells JM: curability of tumors bearing herpes simplex virus thymidine kinase gene. J Natl Cancer Inst 82: 297-300, 1990.
5. Moolten FL, Wells JM, Heyman RA and Evans RM: Lymphoma regression induced by ganciclovir in mice bearing a herpes thymidine kinase transgene. Human Gene Ther 1: 125-134, 1990.
6. Freemann SM, McCune C, Angel C, Abraham GN and Abbound, CN: Treatment of ovarian cancer using HSV-TK gene midified vaccine-regulatory issues. Hum Gene Ther 3: 342-349, 1992.
7. Ezzeddine ZT, Martuza RA, Platika D, Short MP, Malick A, Choi B and Breakefield XO: Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes virus thymidine kinase. New Biol 3: 608-614, 1991.
8. Chen SH, Shine HD, Goodman JC, Grossman RG and Woo SL: Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc Natl Acad Sci USA 91: 3054-7, 1994.
9. Chen SH, Chen XH, Wang Y, Kosai K, Finegold MJ, Rich S and Woo SL: Combination gene therapy for liver metastasis of colon carcinoma in vivo. Proc Natl Acad Sci USA 92: 2577-2581, 1995.
10. O'Malley BWJ, Chen SH, Schwartz MR and Woo SL: Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res 55: 1080-1085, 1995.
11. Tong XW, Block A, Chen SH, Woo SLC and Kieback DG: Adenovirus-mediated gene therapy of human epithelial ovarian cancer by transduction with the thymidine kinase gene and exposure to ganciclovir. Anticancer Res 16: 1611-1618, 1996.
12. Tong XW, Block A, Chen SH, Contant CF, Agoulnik I, Blankenburg K, Kaufman RH, Woo SLC and Kieback DG: In vivo gene therapy of ovarian cancer by adenovirus-mediated thymidine kinase gene transduction and gunciclovir administration. Gynecol Oncol 61: 175-179 1996.
13. Berek JS, and Hacker NF: Practical Gynecologic Oncology. Baltimore, Williams & Wilkins, 1989 pp1-342.